Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
JAMA Dermatol
; 150(8): 901-3, 2014 Aug.
Article
in En
| MEDLINE
| ID: mdl-24919481
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Antibodies, Monoclonal, Humanized
/
Immunologic Factors
/
Melanoma
/
Nevus
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
JAMA Dermatol
Year:
2014
Document type:
Article
Affiliation country:
France
Country of publication:
United States